Roobol MJ - Search Results

1

Active Surveillance for Prostate Cancer: Past, Current, and Future Trends.

de Vos II, Luiting HB, Roobol MJ. de Vos II, et al. Among authors: roobol mj. J Pers Med. 2023 Apr 3;13(4):629. doi: 10.3390/jpm13040629. J Pers Med. 2023. PMID: 37109015 Free PMC article. Review.

2

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

Roemeling S, Roobol MJ, Postma R, Gosselaar C, van der Kwast TH, Bangma CH, Schröder FH. Roemeling S, et al. Among authors: roobol mj. Eur Urol. 2006 Sep;50(3):475-82. doi: 10.1016/j.eururo.2006.04.019. Epub 2006 May 3. Eur Urol. 2006. PMID: 16713065

3

The Prostate cancer Research International: Active Surveillance study.

Bangma CH, Bul M, Roobol M. Bangma CH, et al. Curr Opin Urol. 2012 May;22(3):216-21. doi: 10.1097/MOU.0b013e328351dcc7. Curr Opin Urol. 2012. PMID: 22453333 Review.

4

Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.

Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boevé ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strölin P, van Muilekom E, Schröder FH, Bangma CH, Roobol MJ. Bul M, et al. Among authors: roobol mj. Eur Urol. 2013 Apr;63(4):597-603. doi: 10.1016/j.eururo.2012.11.005. Epub 2012 Nov 12. Eur Urol. 2013. PMID: 23159452 Clinical Trial.

5

A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.

Venderbos LD, van den Bergh RC, Roobol MJ, Schröder FH, Essink-Bot ML, Bangma CH, Steyerberg EW, Korfage IJ. Venderbos LD, et al. Among authors: roobol mj. Psychooncology. 2015 Mar;24(3):348-54. doi: 10.1002/pon.3657. Epub 2014 Aug 20. Psychooncology. 2015. PMID: 25138075

6

Active surveillance for prostate cancer: a legal perspective.

Venderbos LD, Roobol MJ, de Hoogh AN. Venderbos LD, et al. Among authors: roobol mj. Am J Clin Exp Urol. 2014 Dec 25;2(4):323-31. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25606578 Free PMC article.

7

Active surveillance for prostate cancer: a narrative review of clinical guidelines.

Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ; Movember GAP3 consortium. Bruinsma SM, et al. Among authors: roobol mj. Nat Rev Urol. 2016 Mar;13(3):151-67. doi: 10.1038/nrurol.2015.313. Epub 2016 Jan 27. Nat Rev Urol. 2016. PMID: 26813955 Review.

8

Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.

Schoots IG, Osses DF, Drost FH, Verbeek JFM, Remmers S, van Leenders GJLH, Bangma CH, Roobol MJ. Schoots IG, et al. Among authors: roobol mj. Transl Androl Urol. 2018 Feb;7(1):132-144. doi: 10.21037/tau.2017.12.29. Transl Androl Urol. 2018. PMID: 29594027 Free PMC article.

9

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ. Verbeek JFM, et al. Among authors: roobol mj. J Pers Med. 2019 Apr 22;9(2):19. doi: 10.3390/jpm9020019. J Pers Med. 2019. PMID: 31013571 Free PMC article.

10

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.

Tomer A, Rizopoulos D, Nieboer D, Drost FJ, Roobol MJ, Steyerberg EW. Tomer A, et al. Among authors: roobol mj. Med Decis Making. 2019 Jul;39(5):499-508. doi: 10.1177/0272989X19861963. Epub 2019 Jul 18. Med Decis Making. 2019. PMID: 31319751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page